|
|
|
|
|
|
by CaliforniaKarl
779 days ago
|
|
|
You might not get the price-benefits you expect. If the only remaining allowed use for R-12 is in inhalers, the manufacturing volume might be so low that you end up in a similar situation to today: Fewer manufacturers (likely just one), higher prices, and supply-chain issues. |
|
|